Background: RNA interference (RNAi) is a phenomenon in which introduced double-stranded RNAs (dsRNAs) silence gene expression through specific degradation of their cognate mRNAs. Recent analyses in vitro suggest that dsRNAs may be copied, or converted, into 21-23 nucleotide (nt) guide RNAs that direct the nucleases responsible for RNAi to their homologous mRNA targets. Such small RNAs are also associated with gene silencing in plants.
Background
In many eukaryotic cells, when double-stranded RNA (dsRNA) complementary to an endogenous gene is introduced, it can specifically and effectively inhibit expression of its cognate gene [1] [2] [3] [4] . This curious phenomenon of RNA interference (RNAi) is thought to be related to normal host defenses against viruses and to restrict the movement of transposable elements [1, 2, [5] [6] [7] [8] . Because of its efficacy, specificity and generality, RNAi has been adapted for genetic analysis in organisms spanning the breadth of eukaryotic phyla. In plants, dsRNAs can silence genes before RNA synthesis, by DNA modification, as well as after transcription by reducing steady-state mRNA levels (reviewed in [9] ). In animals, dsRNA appears only to induce post-transcriptional gene silencing (PTGS), as dsRNA reduces mRNA levels without causing DNA alterations, and the inhibitory effect can be inherited in the absence of the cognate gene [10, 11] .
The most remarkable feature of RNAi is its specificity; dsRNA inhibits expression of the gene that encodes the dsRNA without affecting the expression of unrelated sequences [1, 10, 12, 13] . The available evidence indicates that dsRNA targets its cognate mRNA species for degradation. Specifically, dsRNAs corresponding to exon sequences are active in RNAi, whereas those corresponding to introns are not [1] . In addition, exonic dsRNAs have been found to reduce the levels of mRNAs in vivo [1, [12] [13] [14] while having little or no effect on the levels of pre-mRNA species [10, 13] .
The sequence specificity of RNAi implies that basepairing interactions between dsRNA, or a product of the dsRNA, and the mRNA are likely to mediate target specificity. Two recent papers addressing the mechanism of RNAi in vitro offer support for this idea, and suggest that small 21-23 nucleotide (nt) RNAs may be the agents responsible for dsRNA-induced gene silencing [14, 15] . These small RNAs have been found in extracts prepared from cultured Drosophila cells [14] , and can be produced in embryo lysates treated with dsRNA [15] . Importantly, 21-23 nt RNAs are associated with dsRNA-induced nucleases capable of carrying out sequence-specific mRNA degradation in vitro [14] . Similar sized RNAs have also been detected in plants, where their abundance is correlated with the extent of PTGS [16] , raising the possibility that 21-23 nt RNAs are a universal feature of PTGS.
The amplification inherent in the processing of large dsRNA into smaller species could also explain the finding that only a few molecules of dsRNA are required to inhibit expression of mRNA species present in far higher concentrations [1, 2, 10, 12] . The ability of dsRNA to act sub-stoichiometrically could be further enhanced if the small RNA-containing nucleases recycle, or are regenerated, after interaction with their targets [14, 15, 17] . It is also possible that dsRNA, or processed 21-23mers, could serve as templates for an RNA-dependent RNA polymerase (RdRP), with new RNA synthesis accounting for signal amplification and for the long-lived RNAi effects seen in C. elegans and plants [9, 11] . Support for indirect amplification comes from the discoveries that the Neurospora crassa qde-1, Caenorhabditis elegans ego-1 and Arabidopsis thaliana SDE1/SGS2 genes, which function in PTGS, encode homologs of plant and viral RdRPs [18] [19] [20] [21] .
Despite the considerable appeal and explanatory power of models invoking small RNAs, there is, as yet, little evidence that the 21-23 nt RNAs identified in vitro mediate RNAi in vivo. To study the mechanisms underlying RNAi, we have developed a quantitative in vivo RNAi assay that exploits the ability of single Drosophila embryos to express luciferase from injected plasmid or mRNA templates. The assay recapitulates the properties of dsRNA-directed inhibition of endogenous genes and has allowed us to quantify important parameters of the RNAi reaction including its dsRNA concentration and size dependence. We have found that RNAi-induced mRNA degradation can occur in the apparent absence of RNA synthesis and is strictly correlated with the production of processed 21-23 nt RNAs. Our findings agree with those obtained in vitro [14, 15] , and provide strong support for the hypothesis that large dsRNAs are rapidly processed into 21-23 nt guide RNAs that provide the sequence specificity of the RNAi reaction. On the basis of the ability of excess sense or antisense RNAs to inhibit RNAi, and the resistance of purified 21-23mer species to RNase, we suggest that the nucleases responsible for RNAi contain both strands of the processed dsRNA.
Results
Our quantitative assay to study RNAi in Drosophila uses plasmid DNA or mRNA templates encoding two unrelated luciferase reporter genes. These were co-injected with dsRNA molecules into early embryos; dsRNA of one luciferase gene was used to inhibit expression from the cognate template, with the other luciferase serving as an internal control. To express the luciferase genes from DNA templates, we injected plasmid fusions between the early acting, uniformly expressed sisA and sisB promoters [22] , and the luciferase genes F-luc from firefly, and R-luc from Renilla reniformis (sea pansy). For the mRNA experiments, we injected in vitro synthesized capped and polyadenylated F-luc and R-luc mRNAs (Figure 1 ). Control embryos collected 3 hours after injection (during gastrulation) possessed high luciferase activity, and the ratio of the two luciferase activities (R-Luc:F-Luc) was reproducible. Accordingly, dsRNA function was assessed by measuring its effect on the ratio of the two luciferase activities in individual embryos that developed normally 3 hours after injection.
Specific inhibition by dsRNA of expression from cognate plasmid or mRNA templates
To test whether dsRNAs can inhibit expression from plasmid templates, we co-injected ~600 bp dsRNA molecules and R-luc and F-luc reporters into embryos. We found that dsR-602 RNA (see Figure 1 ) was a potent (265-fold) inhibitor of R-luc expression and that dsF-600 RNA (see Figure 1 ) was an effective (160-fold) inhibitor of F-luc expression (Figure 2a ). This reciprocal effect on the R-Luc:F-Luc ratio indicates that the dsRNAs acted in a sequence-specific manner without affecting expression from the non-complementary control templates. The specificity of inhibition was further supported by the observation that neither polyI-polyC, nor unrelated dsRNAs from the endogenous Sxl or Escherichia coli lacZ genes affected the ratio of the two luciferase activities (Figure 2a , and data not shown).
The dsR-602 and dsF-600 RNAs exhibited a 40-50-fold inhibition of luciferase activity from in vitro synthesized mRNAs, suggesting that dsRNA is also an effective and specific silencer of mRNA templates (Figure 2b ). Because Reporter plasmids, mRNAs and dsRNAs. The R-luc and F-luc reporter genes used to produce mRNA in vivo and in vitro, and dsRNA in vitro are shown. In vivo, mRNAs initiated from sisA or sisB promoters (P) and ended at the SV40 poly(A) sequence. In vitro, m7G capped mRNAs initiated at the phage T7 promoter and terminated with a run of 30 A residues. The locations and sizes of dsRNAs and single-stranded RNAs (ssRNAs) are indicated by the double lines and numbers on the right. The RNAs are designated by their size and whether they are derived from R-luc or F-luc; for example, dsR-602 RNA refers to the 602 bp dsRNA derived from R-luc, snR-280 is the 280 nt sense strand of R-280, and asR-280, the antisense strand. For RNAs with intron and exon sequences, the length of exon sequences are shown in parentheses. The position of relevant single nucleotide differences between F-luc sequences in the pGL2 and pGL3 vectors are indicated at expanded scale. control experiments showed that ~30% of total luciferase activity was produced within 20 minutes of mRNA injection (data not shown), we initially injected the dsRNAs first, followed 20 minutes later by the mRNA templates to ensure efficient RNAi. Later, we found that co-injection of mRNA and dsRNA produced a comparable degree of inhibition, suggesting that injected dsRNA acts rapidly to silence expression in vivo (Figure 2c ).
Concentration dependence of dsRNA inhibition
To characterize further the RNAi reaction, we examined its dependence on dsRNA concentration. We found that thẽ 600 bp dsRNAs effectively inhibited expression from plasmid and mRNA templates when the injection buffer contained ≥ 0.1 µM dsRNA (Figure 2d ,e). There was a sharp transition from no effect, to fully inhibiting, over a narrow range of concentrations below 0.1 µM (Figure 2d ,e). Assuming 0.1 nl injection, and 7.3 nl embryo volumes, we estimated that the saturating in vivo concentration of dsRNA was ~1.3 nM. This is less than the ~25 nM concentration required to completely silence endogenous genes in Drosophila embryos, but greater than the minimal ~0.4 nM concentration at which inhibition has been observed [12, 23] .
To confirm that dsRNA, and not trace ssRNA contaminants were responsible for inhibition, we compared the inhibitory ability of dsRNA with that of the corresponding sense and antisense RNAs. We found that sense-strand RNAs were incapable of inhibiting R-Luc or F-Luc activity even when injected in 30-60-fold excess of the minimum saturating dsRNA concentrations (Figure 2d,e) . High concentrations of antisense R-602 RNA did, however, inhibit expression from plasmid templates (Figure 2d ). We do not know whether this reflects conventional antisense inhibition of R-luc expression, the formation of dsRNA in vivo, or low-level contamination of the antisense R-602 sample with dsRNA. Regardless of mechanism, the much greater potency of dsRNA indicates that the inhibitory effects were due primarily to dsRNA.
Dependence of inhibitory activity on dsRNA size
Short dsRNA molecules have been reported to be less potent inhibitors than long dsRNAs. Nevertheless, RNAi effects have been observed with dsRNAs as small as 190 bp in C. elegans and 59 bp in Trypanosoma brucei [13, 24] . To determine the relationship between dsRNA length and RNAi efficiency in Drosophila, we synthesized double-stranded R-luc RNAs of various sizes ( Figure 1 ) and assayed their effects at saturating dsRNA concentrations. We found a linear relationship between dsRNA length and the log value of inhibition for dsRNAs between ~80 and 900 bp (Figure 3a) . While confirming previous qualitative assessments that large dsRNAs are more potent than small ones, the log-linear relationship indicates that dsRNAs become disproportionately more effective with increasing size.
Rapid induction of degradation of cognate mRNAs by dsRNA in vivo
The available evidence suggests that RNAi works by targeting mature mRNA species for degradation [1, 10, [13] [14] [15] 23] . Consistent with the specificity for mRNA, we found that dsRNAs containing the 137 bp R-luc intron and up to 23 bp of flanking exon sequence failed to inhibit R-luc expression ( Figure 3a ). To determine whether dsRNA induces the degradation of target mRNA sequences in Drosophila embryos, we examined the fate of R-luc and F-luc mRNAs injected in the presence or absence of dsRNA. Using a northern blot assay, we found that R-luc and F-luc mRNA decay was greatly accelerated by co-injection of the cognate dsRNAs ( Figure 3b ). Indeed, most dsRNA-induced degradation occurred within thẽ 10 minute period between mRNA injection and initial sampling, as the relative R-luc and F-luc mRNA levels were depressed by 10-30-fold in the first time points we could analyze ( Figure 3b ). As expected, unrelated dsRNA was without effect (data not shown).
dsRNAs are processed to 21-23 base species in vivo
Recently, Zamore et al. [15] reported that dsRNAs are processed to small ~21-23 nt sequences in Drosophila embryo extracts. Similar small RNAs are associated with a dsRNA-dependent nuclease purified from cultured cells [14] , making it likely that such RNAs serve as the specificity determinants in the RNAi reaction, an inference supported by the pattern of target mRNA degradation in vitro [15] . To determine whether dsRNAs could be processed quickly enough to account for the rapid inhibition we observed, we injected 32 P-labeled dsR-800 RNA into embryos and monitored for the appearance of small 32 P-labeled RNAs by polyacrylamide gel electrophoresis. Injected dsRNAs were processed into ~21-23 nt species within 10 minutes, and the small RNAs persisted throughout the 3 hour assay ( Figure 4 ). As was seen in vitro [15] , 21-23 nt RNAs were formed in the absence of target ssRNAs, when either of the two strands were labeled, or when dsRNAs were treated with RNase T1 before injection (data not shown), demonstrating that the 21-23 nt RNAs were the products of dsRNA cleavage.
New RNA synthesis seems not to be required for RNAi
In Neurospora, C. elegans and Arabidopsis, RdRP homologs are important for aspects of PTGS [18] [19] [20] [21] . This raises the possibility that RNAi could be mediated indirectly, by transcribed products of dsRNA molecules, rather than directly by the full-length or processed dsRNAs. An experiment to distinguish between these possibilities is to test RNAi activity under conditions where RNA synthesis should not occur. We used the RNA chain-terminating substrate cordycepin (3′deoxyATP) to inhibit RNA synthesis, as in principle, it can block all RNA chain elongation. We first confirmed that cordycepin blocked embryonic development and expression of R-luc plasmid DNA without affecting translation of co-injected F-luc mRNA (data not shown). We then compared the ability of sub-stoichiometric amounts of dsF-600 and dsR-602 RNAs to inhibit expression from F-luc and R-luc mRNAs in the presence and absence of a cordycepin concentration approximately twice that of the ATP pool. We found that RNAi activity was unaffected by the inhibitor: dsF-600 RNA strongly reduced F-luc expression with or without cordycepin, and dsR-602 caused a 30-40-fold decrease in R-luc expression under both conditions (Figure 5a ). Although these results support the idea that new RNA synthesis is not required for RNAi activity in vivo, it is possible that very small RNA molecules could be produced even in the presence of a chain-terminating substrate. To obtain additional evidence as to whether dsRNAs or their products act directly or indirectly, we examined the strand dependence of the RNAi reaction.
The antisense strand of dsRNA determines RNAi specificity
If full-length dsRNA or processed 21-23 nt species target mRNAs directly through base pairing, the sequence of the antisense strand would be the critical determinant of target specificity. If targeting is indirect, through production of complementary antisense transcripts, the sensestrand sequence of the dsRNA should determine specificity.
To test the relative importance of the two strands, we compared the RNAi activity of dsRNAs when one or the other of the strands contained mismatches with the target mRNA. The F-luc reporter genes in the vectors pGL2 and pGL3 differ in sequence because of optimization of codon usage ( Figure 1 ). Taking advantage of these base changes, we made mismatched dsRNAs with one strand from GL2 and one from GL3 and measured their ability to inhibit expression from a GL3 DNA template. In experiments with a 152 bp dsRNA, the perfectly paired control GL3-GL3 dsF-152 RNA caused a 33-fold inhibition of F-luc expression (Figure 5b ). When a sense GL2-antisense GL3 dsRNA (9% mismatch) was used, there was a potent, 17-fold inhibition. In contrast, the reversed sense GL3-antisense GL2 dsRNA, which should pair poorly with the GL3-derived mRNA, was incapable of mediating a significant RNAi reaction (Figure 5b ). To confirm that these results reflected altered pairing properties of the sense-and antisense-strand sequences rather than differential stability of the two mismatched dsRNAs, we modified the experiment so that the mRNA target was derived from a GL2 template. In this case, we found that the sense GL3-antisense GL2 dsRNA mediated a potent RNAi reaction whereas the activity of the sense GL2-antisense GL3 molecule was greatly impaired (Figure 5b ). Taken together, these results suggest that the antisense strand is the determinant of target specificity, as predicted by the direct interaction model.
In the experiment with the GL3 template, the perfectly paired but mRNA mismatched GL2-GL2 dsRNA was more active than was the imperfectly paired and mismatched GL3-GL2 dsRNA (Figure 5b ). This could reflect the added effects of imperfect pairing on dsRNA processing and on hybridization to the target message. To determine whether the mismatched dsRNAs were processed less efficiently than the perfectly paired molecules, we examined the production of 32 P-labeled 21-23 nt RNAs from the various dsF-152 templates. We found that, within experimental error, 23 nt RNAs were produced with similar efficiency from the mismatched and perfectly paired templates (Figure 5c ). An alternative explanation for the reduced activity of mispaired and mismatched dsRNAs could be that mispairing affects a step between dsRNA processing and mRNA target recognition by the antisense strand. If so, this would suggest that the 21-23mer species may remain base-paired after processing. In support of this, we found that purified 21-23 nt RNAs produced from GL2-GL2 and GL3-GL3 templates were partially resistant to RNase A or T1 digestion, suggesting they may be double stranded (Figure 5c and data not shown.) The 21-23mers produced from mismatched templates were, however, sensitive to RNase digestion, suggesting that they were single stranded or sensitive to denaturation under our experimental conditions (data not shown). Although these results hint that the processed 21-23 nt RNAs may be base-paired in vivo, we cannot rule out the possibility that the 21-23 bp species formed in vitro after isolation of the RNA samples.
RNAi can be inhibited by excess unrelated dsRNA
If the initial step in RNAi is the processing of a dsRNA to 21-23 nt guide RNAs, the activation event is likely to be
Figure 4
Double-stranded RNA is rapidly processed into 21-23 nt species in vivo. dsR-800 RNAs, uniformly labeled with 32 P on either the sense or antisense strand, were injected into embryos, and RNA was sampled at the indicated times thereafter. For each time point, 20 embryos were collected and quick frozen before RNA extraction. Lanes marked 0 contain uninjected samples. Samples were electrophoresed on 6% denaturing polyacrylamide gels. M, 32 P-labeled 10 bp DNA ladder (Gibco-BRL). Antisense Sense mediated by a non-specific dsRNA binding/cleavage activity. If so, it should be possible to inhibit the RNAi reaction by adding excess unrelated dsRNA. To test this, we injected double-stranded R-luc RNAs along with a 40-fold excess of unrelated dsRNA and assayed relative R-Luc expression from plasmid templates. We found that excess R-137i, Sxl and lacZ dsRNAs were effective inhibitors of the RNAi activity of the dsR-80 and dsR-145 molecules, as was the artificial polymer polyI-polyC ( Figure 6a , and data not shown). Because there are no lacZ or polyI-polyC ssRNA targets in the embryos, the dsRNA competitors must interfere with a step before ssRNA target recognition. To further characterize the non-specific dsRNAbinding activity, we studied the concentration dependence of the dsRNA competition reaction using short, 60 bp, and long, 1200 bp, lacZ dsRNAs. We found that both the long and short dsRNA competitors could completely inhibit the RNAi reaction; however, it required approximately 150 times (nt)  -150   2  2  3  3  3  3  3  3  3  3  2  3  3  2   --TI  A  A more of the 60 bp RNA than of the 1200 bp RNA to achieve a given degree of inhibition (Figure 6b ). The 1200 bp RNA was even more effective than would be predicted based on its relative length alone. When corrected for size, the 1200 bp molecule was still 7-8 times more effective an inhibitor than was the 60 bp dsRNA.
Excess complementary sense and antisense RNAs can inhibit RNAi
We have shown that the antisense strand of dsRNA determines mRNA target specificity (Figure 5b ). This suggests that the nucleases responsible for RNAi contain bound antisense strands that base pair with complementary mRNAs, thereby marking them for destruction [14, 15, 17] . If so, it should be possible to inhibit the nucleases by adding an excess of complementary sense-strand RNA to compete for mRNA binding. We examined three different ssRNAs for their ability to block the action of dsR-291 RNA on R-luc expression. Two of these, snR-280 and snR-605, were represented in dsR-291 RNA and complementary to R-luc mRNA, whereas the third, snR-300, was represented in the mRNA but did not overlap with dsR-291 ( Figure 1) . We found that the sense-strand RNAs corresponding to the dsRNA strongly inhibited the RNAi reaction, but that the non-complementary snR-300 was without effect (Figure 7a ).
If the targeting nucleases contain both strands of the processed dsRNA, excess complementary antisense RNA would also be predicted to inhibit the RNAi reaction. However, because high concentrations of antisense RNA inhibited luciferase expression on their own (Figure 2d and data not shown), it was not possible to test this hypothesis using the above protocol. Instead, we exploited the base changes between the GL2 and GL3 F-luc genes to create an antisense RNA that perfectly matched the RNA in the nucleases, but which no longer paired efficiently with the mRNA target, in effect, inhibiting the classical antisense activity of the antisense strand without seriously impairing its interactions with RNAi-specific molecules.
For the experiments shown in Figure 7b (left panel), we used GL2-GL2 dsF-152 RNA to target degradation of GL3-derived F-luc mRNA (9% mismatch). To measure the effect of excess antisense strand, we used a smaller 106 nt GL2 antisense RNA that perfectly matched the GL2 dsRNA, but which had a 13% mismatch with GL3 mRNA. We found that GL2 asF-106 RNA alone had no effect on GL3 F-luc expression (data not shown), suggesting that the mismatches blocked the association of the two ssRNAs. In contrast, the GL2-GL2 dsF-152 RNA caused an 11-fold reduction in GL3 F-luc expression, showing that it possessed an easily measurable RNAi activity (Figure 7b, left  panel) . Critically, when excess GL2 asF-106 RNA was coinjected with dsF-152 RNA, it effectively prevented gene silencing, demonstrating that excess antisense RNA can inhibit the RNAi reaction (Figure 7b, left panel) .
We performed the reciprocal experiment using GL3-GL3 dsF-152 RNA to target degradation of GL2-derived F-luc mRNA and found that excess GL3 asF-106 RNA also appeared capable of inhibiting the RNAi reaction (Figure 7b, right panel) . This experiment included a control demonstrating that excess unrelated single-strand RNA had no effect on the reaction, as was seen in the sense-strand competition experiments.
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Figure 7
Excess homologous single strands can inhibit RNAi. (a) Competition with excess sensestrand RNAs. The injection buffer contained expression plasmids, plus or minus dsR-291 RNA (0.15 µM) and snR-300, snR-280 or snR-605 ssRNAs (12 µM); snR-280 and snR-605 overlap with dsR-291, snR-300 does not. (b) Competition with excess antisense RNA. Left, R-luc and GL3-based F-luc expression plasmids were injected, plus or minus GL2 dsF-152 RNA (0.15 µM) and GL2 asF-106 RNA (6 µM), 2.0 µm F-luc and R-luc RNA. Right, buffer contained R-luc and GL2-based F-luc plasmids, plus or minus GL3 dsF-152 RNA (0.15 µM), lacZ (1200 bp) sense-strand RNA (1 µM), or GL3 asF-106 RNA (6 µM). The large variation in samples injected with the GL3 asF-106 RNA (right) was primarily due to 5 (of 18) embryos that did not respond to asF-106 RNA. For the other 13 embryos, the mean F-to R-luc ratio was 0.11 (± 0.067). 
Discussion

21-23 nucleotide RNAs
The involvement of processed small RNAs in RNAi [14] [15] [16] is supported by our finding that processed 21-23 nt RNAs appeared within ~10 minutes of dsRNA injection, and that their levels were maintained throughout the period when dsRNA exerted its inhibitory effects (Figure 4) . The rapid processing of dsRNA to the presumed active form is consistent with the 10-30-fold decrease in cognate mRNA levels observed within ~30 minutes of dsRNA injection (Figure 3b) , and with the potent inhibition of luc expression in experiments where mRNA templates were co-injected with dsRNAs (Figures 2c,5b) . Because one-third of the total Luc activity was produced within ~20 minutes of injection in such co-injection experiments, the strong inhibition of luc expression indicates that dsRNA can target injected mRNA for degradation nearly as fast as it can be targeted for translation. At the other end of the spectrum, in experiments with DNA templates, the vast majority of luciferase activity appeared between 2 and 3 hours, coincident with the period of high-level expression of the sisA and sisB promoters [22] (data not shown). The presence of processed 21-23 nt RNAs 2-3 hours after injection is thus consistent with their involvement in potent inhibition of luc gene expression observed when DNA templates were used (Figures 2,3a,6,7) . Taken together, the temporal correlation between dsRNA-induced gene silencing, and the appearance and persistence of processed 21-23 nt RNAs, provides strong correlative evidence that these small RNAs are the active agents in vivo.
Substoichiometric action
It has been reported that one dsRNA molecule can inhibit more than one target mRNA in C. elegans and Drosophila [1, 12] . Consistent with those findings, we observed full RNAi activity when mRNA was present in a 10-25-fold molar excess over the injected dsRNA (Figure 2e ). Similarly, a 5-fold lower amount of dsRNA induced a 10-30-fold decrease in mRNA levels, suggesting that dsRNA acted substoichiometrically to degrade mRNA in our assay (Figure 3b ). In theory, processing of dsRNAs into active small RNAs could amplify the original gene-silencing signal, making the concentration of 21-23mers equal to or greater than that of the mRNA. However, analysis of injected 32 P-labeled dsRNA (Figures 4,5c) , or of unlabeled dsRNA by northern blot (data not shown), revealed that injected dsRNA was relatively stable, indicating that only a fraction of the dsRNA was converted to 21-23 base species in our experiments. Interestingly, similar results have been found in vitro, where ~15% of input dsRNA are processed in a 2 hour reaction [15] . The incomplete conversion implies that the dsRNA processing machinery is likely to be limiting in the early embryo, an inference consistent with both the saturability of the RNAi reaction (Figure 2d ,e) and the presumed maternal origin of its protein components. Given that only a fraction of dsRNAs was cleaved, dsRNA processing alone is unlikely to fully explain the apparent substoichiometric inhibition by dsRNA, making it likely that individual 21-23 nt RNAs target multiple mRNAs for destruction. We have incorporated this idea into a model for the RNAi mechanism (Figure 8) . The model builds on the in vitro results of Hammond et al. [14] and Zamore et al. [15] and can account for other known properties of RNAi, including its direct action, specificity, size and strand dependence, and sensitivity to dsRNA and ssRNA competitors.
RNAi without new RNA synthesis
An alternative explanation for the ability of dsRNA to act substoichiometrically is that large dsRNAs, or smaller processed products, could serve as templates for an RdRP, and that the newly synthesized RNAs are the active agents in RNAi. Despite genetic links of RdRPs to PTGS in several species [18] [19] [20] [21] , our studies suggest that dsRNA or its processed products can be sufficient to inhibit gene expression without the involvement of new RNA synthesis. Using dsRNAs with mismatched strands, we found that the antisense strand of the dsRNA determines target specificity, the result predicted if full-length or processed dsRNAs directly base pair with the mRNA target, and one contrary to expectations if the active antisense strands arise through transcription of the original template (Figure 5b ). Direct interaction between dsRNA and the mRNA target is also suggested by our observation that an effective RNAi reaction can be mounted in the presence of high concentrations of the RNA chain terminating substrate cordycepin (Figure 5a ).
Although our studies strongly suggest that dsRNAs, or their processed products, can directly mediate RNAi in vivo, they do not imply that other aspects of PTGS are independent of new RNA synthesis. In particular, we did not address long-lived or heritable RNAi, where signal amplification by RdRPs could explain persistent gene silencing [9] , nor did we address situations in which RdRPs may amplify or create silencing signals from transgenes or duplicated loci. In this regard, the finding that Arabidopsis SDE1/SGS2 is required for silencing transgenes but dispensable for anti-viral PTGS responses [20] suggests that the function of RdRPs may be superfluous when large amounts of dsRNAs are introduced directly into cells.
Dependence of RNAi on the length of dsRNA
Numerous results indicate that long dsRNAs are more effective in mediating RNAi than are short dsRNAs [13, 14, 23, 24] . One explanation is that processing of large dsRNAs should generate a greater variety of 21-23 nt RNAs than would similarly processed small dsRNAs. The larger sequence set of 21-23 nt RNAs would thus be capable of interacting with many more sites on target mRNAs, increasing the chance that at least one RNA-containing nuclease will pair with its target sequence and destroy an mRNA. Such a model would predict that RNAi efficiency is a higher order function of dsRNA size, as the concentrations of active fragments and potential target sites should both increase with dsRNA length, a prediction consistent with the log-linear relationship between dsRNA length and RNAi activity shown in Figure 3a . From a practical standpoint, these data offer quantitative support for previous qualitative assessments that larger dsRNAs are more effective at RNAi, and suggest that one should use the largest molecules practical when testing new dsRNAs.
Evidence for a dsRNA activation step
The findings that dsRNAs can be processed into 21-23 nt RNAs ( [15] ; Figure 4 ), or small RNA-containing nucleases [14] , in the absence of cognate ssRNAs argues that dsRNA molecules are activated by a process that does not require interactions with their mRNA target. Activation would appear to be a limiting step in RNAi, as the reaction is saturated at relatively low levels of dsRNA in vivo (Figure 2d,e) , potentiated by long-term incubation with dsRNA in vitro [23] , and competed by excess unrelated dsRNAs in vivo and in vitro ( [23] , and Figure 6 ). While the mechanism by which excess unrelated dsRNA blocks RNAi is speculative, we suspect that lacZ and Sxl dsRNAs compete at the level of processing, and/or nuclease assembly (Figure 8 ), as both dsRNAs can inhibit expression of their cognate genes in vivo ( [14] , and data not shown). The finding that a 60 bp lacZ dsRNA was a disproportionately less effective competitor than was a 1200 bp lacZ dsRNA (Figure 6b ) may indicate that large dsRNAs are more efficiently processed than very small ones, allowing them to compete more effectively for the limited pool of RNAi nuclease precursors.
Evidence for a two-stranded RNAi nuclease
The ability of excess sense-strand RNA to protect mRNA from degradation suggests direct competition for base pairing to the silencing agent (Figure 7a) . Such competition should occur regardless of whether the RNAi nucleases carry one or both dsRNA strands. On the other hand, the ability of excess antisense strand to protect mRNAs (Figure 7b ), as well as the partial resistance of 21-23mers to RNase treatment (Figure 5c ), suggests that both strands of the processed dsRNA are incorporated into individual RNAi nucleases. The presence of both 21-23 nt strands in the RNAi nuclease complex suggests that mRNA binding must involve dissociation of the strands before, or in concert with, mRNA binding ( [17] , and Figure 8 ).
Although excess ssRNA clearly can inhibit RNAi, its ability to do so suggests additional complexities in the substrate recognition and cleavage process. One means of inhibition would be if the RNAi nuclease were irreversibly inhibited by interaction with ssRNAs. This would explain why ssRNAs can protect newly synthesized mRNAs from degradation up to 3 hours after injection (Figure 7 ), but would complicate the issue of nuclease recycling. A second possibility is competitive inhibition, which would require that the ssRNAs compete for RNAi nuclease binding over the entire course of the reaction. Interestingly, we found that co-injected snR-291 RNA can persist up to 3 hours after injection (data not shown), Research Paper dsRNA directly mediates RNAi Yang et al. 1199
Figure 8
Model for RNAi. Double-stranded RNAs are bound and cleaved by a dsRNA-specific nuclease to generate 21-23 bp products. The 21-23 nt sense (black) and antisense (blue) strands are incorporated into a multiprotein RNAi nuclease, perhaps coincident with processing. The bound 21-23 nt antisense strand base pairs with an mRNA target (red). Bound mRNAs undergo endonucleolytic cleavage at one or both double strand-single strand junctions and the base-paired mRNA segment is digested by an associated 3′-5′ exonuclease (gray), perhaps corresponding to the C. elegans mut-7 gene product [8] . The free RNAi nuclease recycles, allowing catalysis. Excess unrelated dsRNAs, such as lacZ or Sxl, compete for the assembly of RNAi nucleases, while excess polyI-polyC could compete by titrating the dsRNA-binding activity ( Figure 6 ). Excess sense and antisense strands are competitive inhibitors of mRNA binding (Figure 7) . When one bound 21-23mer is paired, the other is inaccessible. We have arbitrarily drawn an associative mechanism whereby the mRNA invades the 21-23 bp duplex [17] , rather than a dissociative one in which the 21-23 nt strands separate before interaction with mRNA. Similarly, our data are compatible with nuclease regeneration through strand exchange between bound 21-23mers and mRNA [17] . Cap and poly(A) mark mRNA ends; neither structure is required for RNAi ( [14, 15] , and data not shown). suggesting that short ssRNAs may be cleaved less efficiently than mRNAs. Curiously, a potentially related substrate length dependence has been observed in vitro, as extracts prepared from dsRNA-transfected cells efficiently degrade > 600 nt ssRNAs, but show dramatically reduced activity against shorter transcripts [14] .
Regardless of these complications, competition by excess sense and antisense strands suggests that individual RNAi nucleases can target either RNA strand for degradation. While of little apparent consequence for experiments in which mRNA is the exclusive target, RNAi is likely to reflect natural defenses against viruses and transposable elements. As such, bifunctional nucleases could provide an efficient defense against RNA viruses, as every nuclease could act at each stage of the viral growth cycle.
Materials and methods
In vivo and in vitro RNA synthesis and preparation of dsRNA
The pGL2 and pGL3-derived F-luc expression plasmids carried the sisA promoter. R-luc plasmids (pRL-null) carried the sisB promoter. In vitro mRNA synthesis utilized PCR-derived templates containing a 5′ T7 promoter and 3′ poly(A) sequences. All non-radioactive transcripts were produced in the presence of cap analog m7G(5′)ppp(5′)G. For dsRNA, individual strands were synthesized using phage RNA polymerases and PCR-derived templates carrying a phage promoter at one end. To make dsRNA, equal amounts of sense and asRNA were mixed, heated to 90°C, and reannealed over several hours. Annealing was monitored by ethidium bromide staining of agarose gels. All dsRNA had 18-base single-stranded overhangs because of the template promoter sequences.
Microinjection and luciferase assay of injected embryos
Embryos (0-1 h) were injected under oil according to standard protocols. Needles were connected to a hand-operated air-filled syringe. Approximately 0.1 nl was injected into the center of each embryo. For sequential injections, dsRNA (or buffer) was injected first, followed by mRNA 20 min later. After injection, embryos developed for 3 h at 25°C. Single embryos were assayed using a dual-luciferase system (Promega).
Stability of mRNA and dsRNA
F-luc and R-luc mRNAs, ± cognate dsRNAs, were co-injected into 90-120 embryos. 30 embryos were pooled per time point and RNA was isolated by guanidinium extraction. Five embryo equivalents of RNA were loaded per lane and analyzed by northern hybridization. To measure dsRNA processing, either sense or antisense strands of dsR-928 or dsF-152 were internally 32 P-labeled and mixed with unlabeled complementary strand to make 32 P-dsRNA. In some experiments 32 P-dsRNAs were treated with RNase T1 (2.0 µg/ml) for 15 min at 22°C to eliminate ssRNA contaminants. Labeled dsRNAs were injected and RNA samples prepared as described above except that 10 or 20 embryos were pooled per time point. Some purified RNA samples were treated with RNases A (40 µg/ml) or T1 (3.0 µg/ml) for 1 h at 30°C before analysis.
Supplementary material
Supplementary material including full methodological detail is available at http://current-biology.com/supmat/supmatin.htm.
